COVID-19 Published Guidelines and Reviews

The COVID-19 Scientific Advisory Board has compiled and examined published guidelines and reviews on COVID-19 and have provided a collection of those most helpful and relevant for frontline providers below. New guidelines and reviews will be added to this page on a recurring basis.


To search by keyword, select Ctrl + F on a PC and Command + F on a Mac. Then, enter keyword and Enter.

Governmental Resources

US Food and Drug Administration (FDA)
Coronavirus Disease 2019 (COVID-19) Resource List. US Food & Drug Administration.
In both English and Spanish and continually updated, this website is extensive but provides access to the latest FDA authorization of drugs, vaccines and testing.

Centers for Disease Control and Prevention (CDC)
Guidance for COVID-19.
An extensive, continually updated website with an enormous amount of information. The hundreds of guidance documents are best navigated with the well-placed search function rather than trying to find what you want on your own.

Morbidity and Mortality Weekly Reports
Review the reports recommended by the SAB here.

National Institutes of Health (NIH)
NIH COVID-19 Treatment Guidelines
Excellent, frequently updated, easily navigated website with expert opinions from a diverse panel of academic COVID-19 experts. The “What’s New” and “Table of Contents” provide rapid access to referenced information on all forms of COVID-19 treatment.

Non-Governmental Resources

Infectious Diseases Society of America (IDSA). 11/18/21.
This website provides Infectious Diseases Society of America (IDSA) Guidelines on the Treatment and Management of patients with COVID-19. The IDSA frequently updates the site with their carefully considered and well-organized distillation of current knowledge. In particular, their Summary Table titled, “Overview of COVID-19 Treatment Guidelines” is particularly concise and informative. This IDSA guideline link will be placed in the IARS Published Guidelines and Reviews web page for future reference.

Omicron Variant Patient Profile in South Africa. 12/6/21. SAMRC.
Readers interested in following the progress of the Omicron variant in South Africa, where it was first identified on November 24, 2021, are directed to the website of the South African Medical Research Council (SAMRC). This site provides access to a developing patient profile of the impact of the Omicron surge on hospitalization and outcomes here.

American Society of Anesthesiologists (ASA)
ASA’s Statements and Recommendations on COVID-19. American Society of Anesthesiologists.
This easily navigated COVID-19 resource serves as a statement and guideline website for the American Society of Anesthesiologists and is updated as indicated. Includes 20+ “Statements and Recommendations” that focus on surgery, anesthesia and safety; an extensive “Frequently Asked Questions” section; and a variety of other resources including webinars and podcasts.

Society of Critical Care Medicine (SCCM)
At this site SCCM offers a variety of COVID-19 resources available without membership, including a Rapid Resource Center for educational materials, Surviving Sepsis Campaign COVID-19 Guidelines, COVID-19 journal articles from SCCM publications, and complimentary online training in critical care for non-ICU clinicians.

Elsevier COVID-19 Healthcare Hub
A well-organized collection of clinical resources focused on the latest evidence-based practices, covering symptom management, diagnosis, treatment and ongoing wellness. Provides succinct and well referenced summaries of many aspects of SARS-CoV-2 infection in English and Spanish. It also provides links to other COVID-19 content hubs, including Springer Nature, Wiley, NEJM, BMJ, American Society for Microbiology, American College of Cardiology, etc.

Center for Science in the Public Interest
COVID-19 Evidence Hub. Center for Science in the Public Interest.
CSPI is a fifty-year old independent science-based consumer advocacy organization. This site provides a hub that aggregates more than 35 international databases related to evidence on diagnosis, vaccines, drug treatments, therapeutic interventions and public health measures for COVID-19.

Open Critical Care (OCC)
Open Critical Care Portal: The hub for critical care education tools
OCC is a collaborative recently initiated by the University of California San Francisco (UCSF), partnering with Brigham & Women’s Hospital (BWH) and other organizations such as Partners in Health. Their site is currently in beta mode and offers open access critical care educational resources styled for independent learning as well as institutional curricula. It includes a COVID-19 Guidelines Dashboard that aggregates recommendations from multiple health authorities into a consensus for each therapy, a series of detailed protocols developed at BWH on many aspects of COVID-19, and also apps applicable to acute respiratory failure in general.

Summaries of Special COVID-19 Topics

The Virus, The Vaccines, and The Variants
IARS COVID-19 Resource Newsletter, #98. Posted August 30, 2021. This brief review provides a concise explanation the relationship between the virus, the vaccines and the variants. 27 references.
[Author: Robert N. Sladen, MBChB, FCCM, on behalf of the IARS Scientific Advisory Board]

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
IARS COVID-19 Resource Newsletter, #79. Posted April 21, 2021. This brief review provides a concise explanation of what is known about this rare but newsworthy vaccine induced problem. 5 references.
[Author: Robert N. Sladen MBChB, FCCM on behalf of the IARS Scientific Advisory Board]

IARS COVID-19 Resource Newsletter, #76. Posted April 12, 2021. This is an excellent summary of the prolonged impairment of functional capacity after COVID-19. 30 references.
[Author: Robert N. Sladen MBChB, FCCM on behalf of the IARS Scientific Advisory Board]

NIH Therapeutics Recommendations (Updated March 2, 2022)
Based upon data generated during the Omicron variant surge, the NIH has revised its recommendations for antiviral therapeutics for non-hospitalized patients with mild-moderate COVID-19 at high risk of progression to severe disease. The drugs are ranked by order of preference. For a full list, visit

The material on this website is provided for informational purposes and does not constitute medical advice. New knowledge is added daily and may change over time. Opinions expressed should not be construed as representing IARS policy or recommendations. References and links to third parties do not constitute an endorsement or warranty by IARS.

Thank you IARS COVID-19 Scientific Advisory Board and Content Reviewers!

The IARS would like to recognize the COVID-19 Scientific Advisory Board and the Content Reviewers for sharing their expertise and time to help curate and evaluate the most relevant information coming out about COVID-19 for our members. The COVID-19 SAB meet regularly to discuss articles, provide reviews and determine what information would be most valuable to those on the frontline. The Content Reviewers review a list of articles daily to determine their topic areas and relevance to the audience. We greatly appreciate the commitment they have made to help during this major health crisis!

IARS COVID-19 Scientific Advisory Board

Current Members:

Lydia Cassorla, MD, MBA
Specialty: Anesthesiology
Professor Emerita, Department of Anesthesia and Perioperative Care, University of California, San Francisco
San Francisco, CA

David M. Clement, MD
Specialty: Anesthesiology
St. Joseph Hospital
Winthrop, WA

Robert L. Coffey, MD
Specialty: Pulmonology
Retired Physician
Mount Vernon, WA

Anil Hingorani, MD
Specialty: Vascular Surgery, General Surgery
Vascular Institute Of New York
Brooklyn, NY

Nancy Kenepp, MD
Specialty: Anesthesiology
Associate Professor Emeritus, Temple University, Katz School of Medicine, Department of Anesthesiology
Wynnewood, PA

Philip D. Lumb, M.B., B.S., M.D., MCCM, FCCP
Specialty: Cardiac Anesthesiology, Critical Care Medicine
Professor of Anesthesiology
Professor of Trauma Surgery
Director of Research and Data Analytics, Department of Anesthesiology
Keck School of Medicine of the University of Southern California
Los Angeles, CA

Edward S. Schulman, MD, FCCP, FAAAAI, FCPP
Specialty: Pulmonary, Critical Care and Sleep Medicine
Professor of Medicine
Director (1987-2012), Division of
Pulmonary, Critical Care and Sleep Medicine
Associate Chairman of Medicine for Research (1995-2000)
Director, Allergy and Asthma Research Center
Director, Pulmonary Physiology Laboratory
Drexel University College of Medicine
Philadelphia, PA

Jagdip Shah, MD, MBA
Specialty: Anesthesiology
Associate Professor of Anesthesiology and Critical Care Medicine, Department of Anesthesiology, Medical College of Virginia - Virginia Commonwealth University School of Medicine
Midlothian, VA

W. Heinrich Wurm, MD
Specialty: Anesthesiology
Chair Emeritus, Tufts Medical Center
Lovell, ME

Guest Contributors:

Jack Lance Lichtor, MD
Specialty: Anesthesiology
Retired Anesthesiologist; Yale University
New Haven, CT

Barry Perlman, MD, PhD, CMI
Specialty: Anesthesiology
Chair, Informatics Committee, Oregon Society of Anesthesiologists
Eugene, OR

Jay Przybylo, MD, FAAP, MFA
Specialty: Anesthesiology
Associate Professor, Department of Anesthesiology, Northwestern University Feinberg School of Medicine
Glenview, IL

Robert N. Sladen, MBChB, FCCM
Specialty: Anesthesiology, Critical Care Medicine
Allen Hyman Professor Emeritus of Critical Care Anesthesiology, Columbia University Vagelos College of Physicians and Surgeons
Roxbury, CT

IARS Content Reviewers

Jonathan V. Roth, MD
Specialty: Anesthesiology
Chairman Emeritus, Department of Anesthesiology; Staff Anesthesiologist, Albert Einstein Medical Center
Dresher, PA

Eugene I. Tolpin, MD, PhD
Specialty: Anesthesiology
ChristianaCare Health Systems
Wilmington, Delaware

IARS Member Community

To assist members in sharing their COVID-19 experience, ideas, and questions, IARS has partnered with DocMatter to create a community for high-quality, clinical discussions. DocMatter is a networking platform tailored to the specific needs and requirements of the medical community.

Encourage, stimulate, and fund ongoing anesthesia-related research projects that will enhance and advance the specialty, and to disseminate current, state-of-the-art, basic and clinical research data in all areas of clinical anesthesia, including perioperative medicine, critical care, and pain management. The IARS is focused solely on the advancement and support of education and scientific research related to anesthesiology..

Support IARS

The IARS contributes more than $1 million each year to fund important anesthesia research. Your donation will help support innovative and forward-thinking anesthesia research and education initiatives, all of which are designed to benefit patient care. You can feel good knowing that 100% of your donation is directly allocated to research.